Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET	digestive system neuroendocrine neoplasm	Enrolling by invitation	Phase 1 / Phase 2	2025-08-15		NCT05385861

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chang Gung Memorial Hospital	214
China Medical University Hospital	112
Kaohsiung Medical University Chung-Ho Memorial Hospital	56
National Cheng-Kung University Hospital	83
National Health Research Institutes, Taiwan	52
Taipei Veterans General Hospital, Taiwan	80

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chang Gung Memorial Hospital (Lin-Kou),	Linkou District	Taiwan	1
Chang-Gung Memorial Hospital, Kaohsiung	Kaohsiung City	Taiwan	2
China Medical University Hospital	Taichung	Taiwan	54
Kaohsiung Medical University Chung-Ho Memorial Hospital	Kaohsiung City	Taiwan	48
National Cheng-Kung University Hospital	Tainan	Taiwan	5
Taipei Veterans General Hospital	Taipei	Taiwan	64